sj-xls-2-tag-10.1177_17562848211032790 – Supplemental material for Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study

Supplemental material, sj-xls-2-tag-10.1177_17562848211032790 for Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study by Katarina Mitrova, Barbora Pipek, Martin Bortlik, Ludek Bouchner, Jan Brezina, Tomas Douda, Tomas Drasar, Pavel Drastich, Premysl Falt, Pavel Klvana, Vaclav Leksa, Ales Novotny, Pavel Svoboda, Jan Skorpik, Jan Ulbrych, Marek Veinfurt, Blanka Zborilova, Milan Lukas and Dana Duricova in Therapeutic Advances in Gastroenterology

补充材料sj-xls-2-tag-10.1177_17562848211032790，对应Katarina Mitrova、Barbora Pipek、Martin Bortlik、Ludek Bouchner、Jan Brezina、Tomas Douda、Tomas Drasar、Pavel Drastich、Premysl Falt、Pavel Klvana、Vaclav Leksa、Ales Novotny、Pavel Svoboda、Jan Skorpik、Jan Ulbrych、Marek Veinfurt、Blanka Zborilova、Milan Lukas及Dana Duricova发表于《胃肠病学治疗进展》的研究“炎症性肠病女性孕期维多珠单抗（vedolizumab）与乌司奴单抗（ustekinumab）的胎盘药代动力学差异：一项前瞻性多中心研究”。